Bristol Myers Squibb reported $5.14B in Pre-Tax Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbott ABT:US USD 2.49B 486M
ALKERMES ALKS:US USD 136K 7.25M
AstraZeneca AZN:LN USD 3.09B 52M
Biogen BIIB:US USD 821M 53.8M
Coherus Biosciences CHRS:US USD -86650000 36.5M
GlaxoSmithKline GSK:LN GBP 2.43B 602M
Horizon Pharma HZNP:US USD 315.1M 27.58M
Intercept Pharmaceuticals ICPT:US USD -104087000 83.77M
Johnson & Johnson JNJ:US USD 8.07B 98M
Medtronic MDT:US USD 3.73B 2B
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 10.67B 3.11B
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M
Revance Therapeutics RVNC:US USD -83993000 22.56M
Teva Pharmaceutical Industries TEVA:US USD 769M 62M
United Therapeutics UTHR:US USD 312.5M 161.9M